In a recent debate-style panel, five otolaryngologists addressed topical clinical issues relating to the pediatric airway ranging from adenotonsillectomy in children with obstructive sleep symptoms, to whether cidofovir should be used as a standard treatment in children with recurrent respiratory papillomas.
SAN DIEGO-Hearing aids can become a reliable source of ancillary income for otolaryngologists, according to four speakers in the miniseminar, Hearing Aids: The Dollars and Cents of Dispensing, presented at the annual meeting of the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS).
Patients with cancer of the larynx who are treated at teaching and research hospitals that see high volumes of such patients are the least likely to die within a year of their diagnoses, researchers said at the annual meeting of the American Head and Neck Society.
When a 30-year-old woman from Colombia who had had severe stenosis from airway tuberculosis was referred to the University College London Centre for Stem Cells and Regenerative Medicine, there were more questions than answers.
SAN DIEGO-For patients who undergo surgery for obstructive sleep apnea, failure of surgery to achieve success presents a number of challenges to otolaryngologists. First and foremost is the challenge of correctly assessing the outcome of surgery followed by the need to choose additional therapy tailored to the particular needs of each patient.
Are there racial and ethnic disparities in patients with chronic rhinosinusitis presenting for sinus surgery? According to one recent study, the answer is yes. The nasal polyp population consists of a larger portion of nonwhite patients who tend to present with worse disease, and certain subgroups have worse quality-of-life scores.
Injection laryngoplasty (IL) performed in the office with the patient awake yields similar results as when it is performed with the patient asleep, researchers have found in a case-control study.
The otolaryngologists and pediatric surgeons who watched President Obama’s July 22 press conference must have been astonished to hear themselves vilified by the Health Care Reformer-in-Chief.